Sign in

    Saul Hadassin

    Vice President and Equity Analyst at Barrenjoey Capital Partners

    Saul Hadassin is a Vice President and Equity Analyst at Barrenjoey Capital Partners, with a primary focus on Australian-listed companies in the consumer and general sectors. Over his career, Hadassin has covered major firms such as Woolworths, Wesfarmers, Coles, and Metcash, and has earned recognition for his analytical performance, achieving a documented success rate of up to 75% and average returns of approximately 16.74% in prior roles. He began his equity research career at UBS, where he built a track record for insightful stock recommendations before joining Barrenjoey in 2021. Hadassin holds relevant Australian securities credentials and is known for a rigorous, data-focused investment research methodology.

    Saul Hadassin's questions to RESMED (RMD) leadership

    Saul Hadassin's questions to RESMED (RMD) leadership • Q4 2025

    Question

    Saul Hadassin from Barrenjoey asked about the drivers of the low-double-digit U.S. mask growth, seeking to understand the balance between market share gains and stronger overall industry resupply.

    Answer

    CEO & Chairman Michael Farrell attributed the strong performance to both market share gains and enhanced resupply programs. He highlighted product innovation, such as the AirTouch N30i and F40 masks, as a key driver of competitive wins, while also noting that improved resupply efforts through platforms like Brightree and MyAir are boosting volumes beyond the high-single-digit market growth rate.

    Ask Fintool Equity Research AI

    Saul Hadassin's questions to RESMED (RMD) leadership • Q4 2025

    Question

    Saul Hadassin from Barrenjoey asked about the drivers of the strong U.S. mask growth, seeking to understand the balance between market share gains and overall resupply strength.

    Answer

    CEO Michael Farrell attributed the outperformance to both factors. He highlighted product innovation, like the AirTouch N30i mask, as a key driver of share gains, while also crediting enhanced resupply programs through platforms like Brightree and MyAir for boosting overall growth beyond the market rate.

    Ask Fintool Equity Research AI

    Saul Hadassin's questions to RESMED (RMD) leadership • Q3 2025

    Question

    Saul Hadassin from Barrenjoey questioned why the Q4 gross margin guidance was 'broadly consistent' rather than materially higher, given favorable current foreign exchange rates.

    Answer

    CFO Brett Sandercock acknowledged the question, explaining that the 'broadly consistent' guidance provides some flexibility. He then conceded that if current foreign exchange rates, particularly the Euro, hold, the bias for the Q4 gross margin would likely be 'north of' the 59.9% reported in Q3.

    Ask Fintool Equity Research AI

    Saul Hadassin's questions to RESMED (RMD) leadership • Q1 2025

    Question

    Saul Hadassin questioned the working capital performance, specifically asking about the drivers behind the inventory build during the quarter.

    Answer

    CFO Brett Sandercock explained that the inventory increase was a deliberate part of a strategy to rebalance freight methods. By increasing stock-in-transit via sea freight to mitigate higher air freight costs, inventory levels temporarily rose. He expects this to stabilize after the second quarter.

    Ask Fintool Equity Research AI